Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1992 1
1994 1
1995 3
1996 3
1997 2
1998 1
1999 1
2002 2
2003 2
2004 1
2005 3
2006 2
2007 1
2008 1
2009 1
2011 4
2012 6
2013 7
2014 3
2015 2
2016 5
2017 5
2018 6
2019 9
2020 8
2021 9
2022 10
2023 7
2024 9
2025 7
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

114 results

Results by year

Filters applied: . Clear all
Page 1
Tumor-Infiltrating Lymphocytes and Survival Outcomes in Early ERBB2-Positive Breast Cancer: 10-Year Analysis of the ShortHER Randomized Clinical Trial.
Dieci MV, Bisagni G, Bartolini S, Schirone A, Cavanna L, Musolino A, Giotta F, Rimanti A, Garrone O, Bertone E, Cagossi K, Sarti S, Ferro A, Piacentini F, Orvieto E, Sanders M, Miglietta F, Massa D, Balduzzi S, Conte P, D'Amico R, Guarneri V. Dieci MV, et al. Among authors: giotta f. JAMA Oncol. 2025 Apr 1;11(4):386-393. doi: 10.1001/jamaoncol.2024.6872. JAMA Oncol. 2025. PMID: 39946142 Free PMC article. Clinical Trial.
A Multicenter Real-Life Evaluation of Safety and Effectiveness of the Antibody-Drug Conjugate Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer.
Martorana F, Sanò MV, Fabi A, Paris I, Leonardi V, Bini G, Maiorana O, Vigneri P, Gebbia V, Scandurra G, Giotta F, Curaba A, Valerio MR. Martorana F, et al. Among authors: giotta f. Am J Clin Oncol. 2025 Sep 1;48(9):450-457. doi: 10.1097/COC.0000000000001201. Epub 2025 May 19. Am J Clin Oncol. 2025. PMID: 40387297
Standard Versus Reduced CDK4/6 Inhibitor Therapy in Elderly Patients with Metastatic Hormone Receptor-Positive, HER2-Negative Breast Cancer: An Observational Multicenter Study.
Fedele P, Landriscina M, Moraca L, Gadaleta-Caldarola A, Cusmai A, Giuliani F, Chiuri V, Giotta F, Pinto A, Mirisola V, Gadaleta-Caldarola G. Fedele P, et al. Among authors: giotta f. J Clin Med. 2024 Dec 6;13(23):7441. doi: 10.3390/jcm13237441. J Clin Med. 2024. PMID: 39685899 Free PMC article.
CDK4/6 Inhibitors in Patients Aged 80 and Older with HR+/HER2- Metastatic Breast Cancer: A Real-World Multicenter Study.
Fedele P, Landriscina M, Moraca L, Cusmai A, Gnoni A, Licchetta A, Lanotte L, Pappagallo MN, Melaccio A, Giordano G, Maselli FM, Giuliani F, Chiuri V, Giotta F, Fumai F, Gadaleta-Caldarola G. Fedele P, et al. Among authors: giotta f. Cancers (Basel). 2025 Oct 13;17(20):3302. doi: 10.3390/cancers17203302. Cancers (Basel). 2025. PMID: 41154360 Free PMC article.
Interaction between tumor-infiltrating lymphocytes and BMI in early HER2-positive breast cancer: analysis of the ShortHER trial.
Dieci MV, Bisagni G, Bartolini S, Cavanna L, Musolino A, Giotta F, Rimanti A, Garrone O, Bertone E, Cagossi K, Sarti S, Ferro A, Piacentini F, Orvieto E, Sanders M, Miglietta F, Balduzzi S, D'Amico R, Conte P, Guarneri V. Dieci MV, et al. Among authors: giotta f. ESMO Open. 2025 Nov;10(11):105832. doi: 10.1016/j.esmoop.2025.105832. Epub 2025 Oct 10. ESMO Open. 2025. PMID: 41075365 Free PMC article. Clinical Trial.
114 results